Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. By Product
1.1.2. By Distribution Channel
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Distribution Channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Subcutaneous Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising prevalence of chronic diseases
3.4.1.2. Increasing production of biologics
3.4.1.3. Increasing product innovations and approvals
3.4.1.4. Increasing focus on self-administration, prevention of needlestick injuries and dosing errors
3.4.2. Market restraint analysis
3.4.2.1. High cost of advanced delivery systems
3.4.2.2. Lack of awareness in developing countries
3.5. Subcutaneous Drug Delivery Devices Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Subcutaneous Drug Delivery Devices Market: By Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Prefilled syringes
4.1.2. Pen injectors
4.1.3. Auto-injectors
4.1.4. Wearable injectors
4.1.5. Needle-free injectors
4.2. Product Market Share, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Subcutaneous Drug Delivery Devices Market, by Product Outlook
4.4.1. Prefilled syringes
4.4.1.1. Prefilled syringes market estimates and forecast, 2016 - 2027 (USD Million)
4.4.2. Pen injectors
4.4.2.1. Pen injectors market estimates and forecast, 2016 - 2027(USD Million)
4.4.3. Auto injectors
4.4.3.1. Auto injectors market estimates and forecast, 2016 - 2027 (USD Million)
4.4.4. Wearable injectors
4.4.4.1. Wearable injectors market estimates and forecast, 2016 - 2027 (USD Million)
4.4.5. Needle-free injectors
4.4.5.1. Needle-free injectors market estimates and forecast, 2016 - 2027 (USD Million)
Chapter 5. Subcutaneous Drug Delivery Devices Market: By Distribution Channel Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospital pharmacies
5.1.2. Retail pharmacies
5.1.3. Online pharmacies
5.2. By Distribution Channel Market Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Subcutaneous Drug Delivery Devices Market by Distribution Channel Outlook
5.4.1. Hospital pharmacies
5.4.1.1. Hospital pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
5.4.2. Retail pharmacies
5.4.2.1. Retail pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
5.4.3. Online pharmacies
5.4.3.1. Online pharmacies market estimates and forecast, 2016 - 2027(USD Million)
Chapter 6. Subcutaneous Drug Delivery Devices Market: Country Estimates & Trend Analysis
6.1. Country Market Share Analysis, 2019 & 2027
6.2. County Market Dashboard
6.3. Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2019
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.7.2. The U.S.
6.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (USD Million)
6.7.3. Canada
6.7.3.1. Canada market estimates and forecast, 2016 - 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.8.2. The U.K.
6.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (USD Million)
6.8.3. Germany
6.8.3.1. Germany market estimates and forecast, 2016 - 2027 (USD Million)
6.8.4. France
6.8.4.1. France market estimates and forecast, 2016 - 2027 (USD Million)
6.8.5. Italy
6.8.5.1. Italy market estimates and forecast, 2016 - 2027 (USD Million)
6.8.6. Spain
6.8.6.1. Spain market estimates and forecast, 2016 - 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.9.2. Japan
6.9.2.1. Japan market estimates and forecast, 2016 - 2027 (USD Million)
6.9.3. China
6.9.3.1. China market estimates and forecast, 2016 - 2027 (USD Million)
6.9.4. India
6.9.4.1. India market estimates and forecast, 2016 - 2027 (USD Million)
6.9.5. South Korea
6.9.5.1. South Korea market estimates and forecast, 2016 - 2027 (USD Million)
6.9.6. Australia
6.9.6.1. Australia market estimates and forecast, 2016 - 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.10.2. Brazil
6.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (USD Million)
6.10.3. Mexico
6.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (USD Million)
6.10.4. Argentina
6.10.4.1. Argentina market estimates and forecast, 2016 - 2027 (USD Million)
6.10.5. Colombia
6.10.5.1. Colombia market estimates and forecast, 2016 - 2027 (USD Million)
6.11. Middle East & Africa
6.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.11.2. South Africa
6.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (USD Million)
6.11.3. Saudi Arabia
6.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
6.11.4. UAE
6.11.4.1. UAE market estimates and forecast, 2016 - 2027 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2019
7.3.4. Gerresheimer AG
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Medtronic Plc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Ypsomed AG
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Elcam Medical Group
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Novo Nordisk
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Insulet Corporation
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Becton, Dickinson and Company
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. West Pharmaceutical Services, Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. PharmaJet
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Inolife Sciences
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Unilife Corporation
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives



List of Tables



List of Tables



Table 1 List of abbreviation
Table 2 North America subcutaneous drug delivery devices market, by region, (USD Million) 2016 - 2027
Table 3 North America subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 4 North America subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 5 The U.S. subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 6 The U.S. subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 7 Canada subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 8 Canada subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 9 Europe subcutaneous drug delivery devices market, by region, (USD Million) 2016 - 2027
Table 10 Europe subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 11 Europe subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 12 The U.K. subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 13 The U.K. subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 14 Germany subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 15 Germany subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 16 Italy subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 17 Italy subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 18 Spain subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 19 Spain subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 20 France subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 21 France subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 22 Asia Pacific subcutaneous drug delivery devices market, by region, (USD Million) 2016 - 2027
Table 23 Asia Pacific subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 24 Asia Pacific subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 25 Japan subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 26 Japan subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 27 Japan others subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 28 China subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 29 China subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 30 India subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 31 India subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 32 South Korea subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 33 South Korea subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 34 Australia subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 35 Australia subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 36 Latin America subcutaneous drug delivery devices market, by region, 2016 - 2027 (USD Million)
Table 37 Latin America subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 38 Latin America subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 39 Brazil subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 40 Brazil subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 41 Mexico subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 42 Mexico subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 43 Argentina subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 44 Argentina subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 45 Colombia subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 46 Colombia subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 47 Middle East and Africa subcutaneous drug delivery devices market, by region, 2016 - 2027 (USD Million)
Table 48 Middle East and Africa subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 49 Middle East and Africa subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 50 South Africa subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 51 South Africa subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 52 Saudi Arabia subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 53 Saudi Arabia subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 54 UAE subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 55 UAE subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)